Intelligence Driven Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Intelligence Driven Advisers's BMY Position: Q2 2026 in Review
Intelligence Driven Advisers reduced its Bristol-Myers Squibb (BMY) stake by 24% in Q2 2026, selling an estimated $72.6K and leaving 3,940 shares worth $227K. The position accounts for 0.04% of the portfolio, ranked #123.
Intelligence Driven Advisers first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $316K in Q1 2026. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Intelligence Driven Advisers held 3,940 shares of Bristol-Myers Squibb worth $227K as of Q2 2026.
- Intelligence Driven Advisers sold 1,265 Bristol-Myers Squibb shares in Q2 2026, an estimated $72.6K.
- Bristol-Myers Squibb made up 0.04% of Intelligence Driven Advisers's portfolio in Q2 2026, its #123 holding.
- Intelligence Driven Advisers first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Intelligence Driven Advisers's Bristol-Myers Squibb position peaked at $316K in Q1 2026.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Intelligence Driven Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.